Gnosis by Lesaffre reinstates its fermentation-derived chondroitin sulfate under the MyCondro™ brand, previously known as Mythocondro®, the world’s first chondroitin sulfate made by fermentation.
Traditionally, chondroitin sulfate supplements have been sourced from animal cartilage, associated with purity concerns and ethical considerations. MyCondro™, thanks to a patented production process through fermentation, overpasses all these limits. The fermentation-based production of MyCondro™ ensures a consistent, high-quality product with over 99% purity. This method eliminates the risk of contamination from animal-derived pathogens.
Furthermore, the structure of MyCondro™ closely resembles human synovial fluid, which may contribute to its efficacy in promoting joint health. Its low molecular weight and homogeneous composition enhance its bioactivity, making it a promising option for individuals seeking to maintain joint function and mobility.
Clinical studies have demonstrated that MyCondro™ boasts a 45% higher bioavailability than bovine-derived chondroitin sulfate. This enhanced absorption suggests lower dosages may be effective, reducing the required daily capsules.
